← Leaderboards
Melina C Claussnitzer
Univ Of North Carolina Chapel Hill
$2,870,758
Attributed
$13,648,685
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$13,648,685 · 3
By mechanism
RC2$8,117,203 · 2
UM1$5,531,482 · 1
Top collaborators
- Anna Louise Gloyn4 shared
- Karen L Mohlke4 shared
- Stephen Cj Parker4 shared
- Orr Ashenberg3 shared
- Noel P Burtt3 shared
- Jason Flannick3 shared
- Evan D Rosen3 shared
- Linus Tzu-Yen Tsai3 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Susan Gaylord$8,096,436
- Cheryl L Giscombe$2,526,036
- Victoria Lin Bae-Jump$4,533,215
- Christy Leigh Avery$11,467,100
- Julie Brumer Dumond$5,578,599
Others in their field
Other Rising Stars on “Chromatin”
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
- Paul Tang · University Of Michigan At Ann Arbor$4,692,033
- Christopher Hartl · Epigenome Technologies, Inc.$4,417,564
- Alexander Federation · Talus Bioscience, Inc.$4,098,558
- Anup Mahurkar · University Of Maryland Baltimore$3,340,487
- Yanling Wang · Rush University Medical Center$2,986,919
Research focus
ChromatinCellsAdipose TissueCommunitiesPathway InteractionsCell TypeNon-Insulin-Dependent Diabetes MellitusAdipocytesVariantUntranslated RnaGenome-WideGenesTraitFunctional DisorderAffectCatalogsPhysiologicalData SetGene Regulatory NetworkGenetic AssociationGenetic VariantGeneticExperimental StudyGene Expression
Grant awards (7)
Investigating Human Adipocyte Heterogeneity$2,149,635
RC2 · FY2025 · DK
Resources to interpret genetic signals and multi-tissue mechanisms for type 2 diabetes and related traits$1,620,238
RC2 · FY2025 · DK
Investigating Human Adipocyte Heterogeneity$2,111,451
RC2 · FY2024 · DK
Bridging the gap between type 2 diabetes GWAS and therapeutic targets$1,767,978
UM1 · FY2024 · DK
Investigating Human Adipocyte Heterogeneity$2,235,879
RC2 · FY2023 · DK
Bridging the gap between type 2 diabetes GWAS and therapeutic targets$1,863,743
UM1 · FY2023 · DK
Bridging the gap between type 2 diabetes GWAS and therapeutic targets$1,899,761
UM1 · FY2022 · DK